Literature DB >> 22105238

Bone: Finding that osteoclasts repel osteoblast activity through Sema4D reveals novel target for bone-boosting therapies.

Emma Leah.   

Abstract

Entities:  

Year:  2011        PMID： 22105238     DOI： 10.1038/nrrheum.2011.175

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  3 in total

Review 1.  New targets for intervention in the treatment of postmenopausal osteoporosis.

Authors:  E Michael Lewiecki
Journal:  Nat Rev Rheumatol       Date:  2011-09-20       Impact factor: 20.543

2.  Suppression of bone formation by osteoclastic expression of semaphorin 4D.

Authors:  Takako Negishi-Koga; Masahiro Shinohara; Noriko Komatsu; Haruhiko Bito; Tatsuhiko Kodama; Roland H Friedel; Hiroshi Takayanagi
Journal:  Nat Med       Date:  2011-10-23       Impact factor: 53.440

Review 3.  Advances in osteoclast biology: old findings and new insights from mouse models.

Authors:  James R Edwards; Gregory R Mundy
Journal:  Nat Rev Rheumatol       Date:  2011-03-08       Impact factor: 20.543
  3 in total
  5 in total

1.  Prevention of alveolar bone loss in an osteoporotic animal model via interference of semaphorin 4d.

Authors:  Y Zhang; L Wei; R J Miron; Q Zhang; Z Bian
Journal:  J Dent Res       Date:  2014-09-24       Impact factor: 6.116

2.  Role of inhibition of osteogenesis function by Sema4D/Plexin-B1 signaling pathway in skeletal fluorosis in vitro.

Authors:  Xiao-Li Liu; Jing Song; Ke-Jian Liu; Wen-Peng Wang; Chang Xu; Yu-Zeng Zhang; Yun Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-10-22

Review 3.  Mini Review Therapeutic Strategies Targeting for Biofilm and Bone Infections.

Authors:  Shizhou Wu; Binjie Wu; Yunjie Liu; Shu Deng; Lei Lei; Hui Zhang
Journal:  Front Microbiol       Date:  2022-06-14       Impact factor: 6.064

Review 4.  Neuropsychiatric lupus: a mosaic of clinical presentations.

Authors:  Shaye Kivity; Nancy Agmon-Levin; Gisele Zandman-Goddard; Joab Chapman; Yehuda Shoenfeld
Journal:  BMC Med       Date:  2015-03-04       Impact factor: 8.775

5.  Bone scaffolds loaded with siRNA-Semaphorin4d for the treatment of osteoporosis related bone defects.

Authors:  Yufeng Zhang; Lingfei Wei; Richard J Miron; Bin Shi; Zhuan Bian
Journal:  Sci Rep       Date:  2016-06-02       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.